DIA
Drug Information Association Logo

Early Bird Extended

The Early Bird Deadline has been extended to 17 March

Save up to €200 when registering before 17 March. Group discounts are also available - contact us for details.

Learn More

Early Bird Extended

The Early Bird Deadline has been extened to 17 March. Save up to €200 when registering before 17 March. Group discounts are also available - Contact us for details.

Learn More

19+ Health Authorities

19+ Health Authorities from Africa will be in attendance at this conference

Come to meet key officials from 19 African countries and discuss best practices, harmonisation and priorities for development of legal framework and health policy.

Learn More

EU QPPV Forum 2015

This Year's QPPV Forum takes place in October

One of the key successes of the Forum is the ability to secure continuing support and involvement from key Regulators. This 9th Forum aims to continue to attract such key speakers and encourage open debate.

Learn More
DIA 2015

Program Co-Chairs Just Announced

The DIA 2015 51st Annual Meeting is the largest multidisciplinary event that brings together a community of more than 7,000 life sciences professionals at all levels and across all disciplines. Register Today!

Learn More

GO 27th Annual EuroMeeting

EuroMeeting

Open Plenary Details Announced
ADVANCING INNOVATION TO COMBAT THE GLOBAL BURDEN OF DISEASE: A CALL TO ACTION
Monday, 13 April 2015 | 16:00 – 17:45 | Grand Amphitheatre (GA Room)

A panel of respected leaders from academia, industry, health agencies, patient advocacy, and the payer community will share perspectives on the dichotomy between evolving diseases, well-known conditions, and neglected and rare diseases, contrasted with the challenges that exist in understanding the physiology of these conditions and developing therapies to treat them.

Keynote Speakers:

  •     Olivier Charmeil, Executive Vice President Vaccines, Sanofi, France
  •     Andrew Morris, Professor, University of Edinburgh, Chairman and Centre Director, Farr Institute, UK

Panellists:

  •     David Haerry, Board of Directors, European AIDS Treatment Group, EU
  •     Hugo Hurts, Executive Director, Medicines Evaluation Board (MEB), the Netherlands
  •     Guido Rasi, Principal Adviser, European Medicines Agency, EU

Register Online (credit card only)

EuroMeeting


     EuroMeeting
   
  EuroMeeting

Download Brochure

     
  Download Registration Form      
   Download Advance Programme  

Group rates available from 7 attendees per organisation. Get in touch with the DIA Contact Centre on +41 61 225 51 51 or diaeurope@diaeurope.org to determine how we can support your employee access to the entire innovation ecosystem in one place.

DIA EuroMeeting 2015: 12 themes designed to Develop, Innovate & Advance healthcare outcomes
through innovation across 5 core competences

Clinical Development | Pharmacovigilance | Regulatory | Health Economics | Quality & Safety

GO From the Editor's Desk

Global Forum

February 2015 Global Forum Now Online: Improved Navigation and Readability:
Stretching less into more has become a familiar clinical trial refrain. This month, your Global Forum reports on Risk-Based Monitoring, an emerging approach that delivers the most benefit to your trials through monitoring targeted to the areas of greatest risk, and focuses on conversations about delivering the right treatment to the right patient at the right time that will continue at our upcoming 27th Annual EuroMeeting and 8th Annual Clinical Forum in Paris.

Read the February issue. Special open access issue, no login required – please share with your colleagues!


Breaking News
TOP NEWS

Ebola Information Resources and Reference Material

CE providers have been asked to share educational resources and reference material from the American Hospital Association (AHA) and the Centers for Disease Control and Prevention (CDC). The information is current as of dates indicated below. Please continue to consult the CDC other public health sources to ensure accuracy and identify additional information that may be available.     

Read Information from the AHA regarding Ebola Facts: Surgical Protocol – Possible or Confirmed Ebola Cases (10/16/14)

Read AHA Ebola Facts: Hospital Preparedness Checklist (10/15/14)

Read CDC Information for Healthcare Workers and Settings

Read AHA Ebola Facts, Educational PowerPoint Slides (10/14/14)

The AHA has provided an Ebola education package for CME providers and believes it would be beneficial to healthcare providers and institutions. (10/14/14)

Read FAQ on Safe Management of Patients with Ebola Virus Disease (EVD) in U.S. Hospitals

      TIRS

Editor In Chief Commentary: Therapeutic Innovation & Regulatory Science - November 2014 Steven P Spielberg MD, PhD discusses recent changes and improvements to the journal and to DIA publications.

Read full commentary.

Read more TIRS articles.

NEW! Read our blog.

Can a Natural Disaster Stall Scientific Research?

An interesting Letter to the Editor appeared in the November issue of DIA’s official journal, Therapeutic Innovation & Regulatory Science, the impact of the Great East Japan earthquake and tsunami in 2011 on research activities is discussed.

Read the full article.


DIA Launches New TIRS Blog

DIA’s journal, Therapeutic Innovation & Regulatory Science, has launched a new blog, titled “Collaborate to Innovate.” The blog aims to further public conversation about global therapeutic advances and regulatory policies by offering expert insight on current trends and fresh perspectives on timely industry news. Read the blog. Don’t forget to follow the blog to stay current on new entries.

The blog is just another facet of TIRS’ multimedia approach to industry news. We also offer monthly podcasts, featuring commentary by industry experts. They are available on the blog. Listen to Podcasts.

Both the blog and our podcasts are complimentary to all site visitors, so please share them with your professional network.


Global Chief Executive Barbara Lopez Kunz and Global Director of Engagement Elizabeth Lincoln were recently interviewed by International Innovation. Courtesy of International Innovation, a leading scientific dissemination service.

Internatioal-Innovation-Cover


SCRIP100.comNew! DIA Europe and Director Jytte Lyngvig were spotlighted in SCRIP100.com.

Read their profile "A Forum for Future Leaders."

What Lies Ahead 2015What Lies Ahead for 2015?

DIA's third annual What Lies Ahead? report, provides expert insight into the year ahead for pharmaceuticals, biotechnology, and the product development of medical devices.

Read report.

DIANew! Content Currents

DIA's Content Currents provides important new global regulatory developments and their impact on pharmaceutical, biotechnology, and medical product development.

Read current issue. 

GO Meetings & Training

Europe-Calendar  


Upcoming educational opportunities in your region:

Plan this year's professional development
for yourself and your team in the following areas:

  • Regulatory Affairs
  • Clinical Research
  • Non-clinical Safety
  • Pharmacovigilance
  • EudraVigilance

DIA Europe's training calendar is updated regularly, remember to check back for additions or changes from time to time.

Keep an overview of dates for conferences and training courses, so you can mark your calendar well in advance.

Search for training courses online

eLearning CatalogeLearning Catalog

Read

GO Member Benefits

MembershipNew! Free access to one of DIA's archived webinars featuring up-to-the-minute information about the latest developments in the medical product industry

Just added! The Impact of Drug Shortages on the Pharmaceutical Industry

More than 18,000 members worldwide look to DIA as the only global, neutral, nonprofit, multidisciplinary association to address the challenges you face every day. Take advantage of all the benefits of membership, including:

DIA ConneXDIA ConneX is a trusted, interactive, web-based network that links DIA’s 18,000-member global community. DIA members use ConneX to collaborate, communicate, network, and exchange information. Through ConneX, DIA members:

  • Share documents
  • Engage in online discussions
  • Post community event information
  • Make announcements and post news
  • Join Communities (formerly SIACs)

 

GO Exhibiting & Advertising

Exhibiting & Advertising Opportunities

Showcase your services, products and expertise to DIA’s highly influential global community of life sciences professionals.

DIA 2015 51st Annual Meeting | 27th Annual EuroMeeting | 8th Annual Clinical Forum | DIA China 2015 7th Annual Meeting 

Upcoming exhibiting opportunities:

Global Forum

Advertise in DIA Publications and Website. Generate Leads through Solution Provider Webinars and White Papers.

View 2015 Media Kit
TIRS

Advertise in DIA’s peer-reviewed journal

View 2015 Rate Card

GO Communities Showcase

Membership

New Era for Communities

DIA is a global member association that provides knowledge resources across the full spectrum of medical product development. In the last few years the organization has expanded that global reach and will continue to grow to meet the need for health care knowledge exchange around the world.

As DIA’s reach expands globally we believe a name change is necessary. Our global volunteers came to consensus on "Community" to replace "SIACs." This change will enhance the visibility of the groups and make it much easier to recognize their purpose.

Each Community is led by a chairperson who is responsible for the overall activities of the Community. View complete list of Community chairpersons.

GO Patient Initiatives

Through DIA’s worldwide conferences and programs, patient representatives have opportunities to develop, strengthen, and support collaborations with policymakers, health professionals, industry representatives, and academia while promoting dialogue and sharing best practices.

The EuroMeeting Patient Fellowship is designed to:

Develop, strengthen, and support patient collaborations with policy makers, health professionals, industry representatives, and academia;

Increase the knowledge and understanding of patient groups about key issues central to patient-centered healthcare, biomedical research, and drug development;

Develop the capacity of patient groups to advocate for change;

Improve alliances between patient groups and other healthcare stakeholders; and

Stimulate cooperation, promote dialogue, and share best practices.